Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults with Symptomatic COVID-19: A Randomized Clinical Trial

Efficacy of Inhaled Ciclesonide for Outpatient Treatment of Adolescents and Adults with Symptomatic COVID-19: A Randomized Clinical Trial

Importance: Systemic corticosteroids are commonly used in treating severe COVID-19. However, the role of inhaled corticosteroids in the treatment of patients with mild to moderate disease is less clear. Objective: To determine the efficacy of the inhaled steroid ciclesonide in reducing the time to a...

Full description

Bibliographic Details
Main Authors: Blaiss, M.S (Author), Clemency, B.M (Author), Gonzalez-Rojas, Y. (Author), Koster, D.J (Author), Morse, C.G (Author), Phipatanakul, W. (Author), Varughese, R. (Author)
Format: Article
Language:English
Published: American Medical Association 2022
Subjects:
Administration, Inhalation
adolescent
Adolescent
adult
Adult
African American
aged
ageusia
all cause mortality
Ambulatory Care Facilities
anosmia
antibiotic agent
antivirus agent
Article
Asian
Black person
chill
ciclesonide
clinical trial
controlled study
coronavirus disease 2019
coughing
COVID-19
disease severity
double blind procedure
Double-Blind Method
drug efficacy
drug safety
drug therapy
dyspnea
emergency ward
epidemiology
female
Female
fever
glucocorticoid
Glucocorticoids
headache
Hispanic
hospital admission
human
Humans
inhalational drug administration
major clinical study
male
Male
metered dose inhaler
Metered Dose Inhalers
middle aged
Middle Aged
monoclonal antibody
multicenter study
multiracial person
myalgia
Native Hawaiian
nonsteroid antiinflammatory agent
organization and management
outpatient
outpatient care
outpatient department
Outpatients
Pacific Islander
paracetamol
phase 3 clinical trial
pregnane derivative
Pregnenediones
randomized controlled trial
sore throat
steroid therapy
thrush
xerostomia
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items